A phase IB/II study of neoadjuvant chemoradiotherapy with CRLX101 and capecitabine for locally advanced rectal cancer.
Michael Joseph Eblan
No relevant relationships to disclose
Hanna Kelly Sanoff
Consultant or Advisory Role - Amgen
Research Funding - Bayer; NCI; Novartis; PCORI
Autumn Jackson McRee
No relevant relationships to disclose
Bert H. O'Neil
No relevant relationships to disclose
Edward Graeme Garmey
Employment or Leadership Position - Cerulean Pharma
Stock Ownership - Cerulean Pharma
Meliessa G. Hennessy
Employment or Leadership Position - Cerulean Pharma
Stock Ownership - Cerulean Pharma
Scott Eliasof
Employment or Leadership Position - Cerulean Pharma
Stock Ownership - Cerulean Pharma
Joel E. Tepper
Research Funding - NIH/NCI
Andrew Wang
Employment or Leadership Position - Coordination Therapeutics
Research Funding - NIH/NCI